Search research articles
Contact Us
Filters
Showing results (141-150 of 159) with videos related to
Page
of 16
Sort By:
Frontiers in Neurology
|
November 16, 2020
Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain Tumors
Lori A Ramkissoon, Worthy Pegram, James Haberberger, et al.
Nature Medicine
|
June 9, 2016
Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases
Jing Ni, Shakti H Ramkissoon, Shaozhen Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients
Eudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.
Translational Oncology
|
August 1, 2021
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors
Jonathan W Riess, Shaila Rahman, Waleed Kian, et al.
Neuro-Oncology
|
September 11, 2021
A molecularly integrated grade for meningioma
Joseph Driver, Samantha E Hoffman, Sherwin Tavakol, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 1, 2019
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures
Adam L Boxer, Michael Gold, Howard Feldman, et al.
Neuro-Oncology
|
June 9, 2019
Barriers to accrual and enrollment in brain tumor trials
Eudocia Q Lee, Ugonma N Chukwueke, Shawn L Hervey-Jumper, et al.
Neuro-Oncology
|
April 17, 2018
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma
Benjamin M Ellingson, Lauren E Abrey, Sarah J Nelson, et al.
Neuro-Oncology
|
February 8, 2017
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas
Ganesh M Shankar, Malak Abedalthagafi, Rachael A Vaubel, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2024
Surgical window of opportunity trial reveals mechanisms of response and resistance to navtemadlin (KRT-232) in patients with recurrent glioblastoma
Veronica Rendo, Eudocia Q Lee, Connor Bossi, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 159) with videos related to
Sort By:
Page
of 16
Frontiers in Neurology
|
November 16, 2020
Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain Tumors
Lori A Ramkissoon, Worthy Pegram, James Haberberger, et al.
Nature Medicine
|
June 9, 2016
Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases
Jing Ni, Shakti H Ramkissoon, Shaozhen Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients
Eudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.
Translational Oncology
|
August 1, 2021
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors
Jonathan W Riess, Shaila Rahman, Waleed Kian, et al.
Neuro-Oncology
|
September 11, 2021
A molecularly integrated grade for meningioma
Joseph Driver, Samantha E Hoffman, Sherwin Tavakol, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 1, 2019
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures
Adam L Boxer, Michael Gold, Howard Feldman, et al.
Neuro-Oncology
|
June 9, 2019
Barriers to accrual and enrollment in brain tumor trials
Eudocia Q Lee, Ugonma N Chukwueke, Shawn L Hervey-Jumper, et al.
Neuro-Oncology
|
April 17, 2018
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma
Benjamin M Ellingson, Lauren E Abrey, Sarah J Nelson, et al.
Neuro-Oncology
|
February 8, 2017
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas
Ganesh M Shankar, Malak Abedalthagafi, Rachael A Vaubel, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2024
Surgical window of opportunity trial reveals mechanisms of response and resistance to navtemadlin (KRT-232) in patients with recurrent glioblastoma
Veronica Rendo, Eudocia Q Lee, Connor Bossi, et al.
Page
of 16